Trials / Completed
CompletedNCT00429923
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)
A Phase 3 Multicenter, Randomized, Double-Masked, Placebo-Controlled Study of the Safety and Efficacy of Difluprednate in the Treatment of Inflammation Following Ocular Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 219 (actual)
- Sponsor
- Sirion Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- —
Summary
The purpose of this phase III study is to determine the efficacy of difluprednate in the treatment of inflammation following ocular surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Difluprednate | |
| DRUG | Difluprednate | |
| DRUG | Placebo |
Timeline
- First posted
- 2007-02-01
- Last updated
- 2009-07-02
- Results posted
- 2009-07-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00429923. Inclusion in this directory is not an endorsement.